Clinical Trial Update: Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating postoperative radiotherapy with Iressa (gefitinib) in advanced head and neck cancer, with a comparison to radiotherapy plus cisplatin a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED